Redline Daptomycin 500MG Injectable Recall: Lack of Processing Controls
Redline Pharmacy Solutions recalls Daptomycin 500MG in 0.9% NACL 100ML injectable due to lack of processing controls. Affected lots: 02242020@3, 02242020@9.
Recall notice
Lack Of Processing Controls
Contact the company
What happened, in plain English
Redline Pharmacy Solutions is recalling Daptomycin 500MG in 0.9% NACL 100ML injectable due to a lack of processing controls. This could lead to medication errors or improper dosing if the product is used without proper quality checks. Read more at govinfonow.com/recall/37360-redline-daptomycin-500mg-injectable-recall-lack-of-processing-controls.
Source Summary by GovInfoNow · govinfonow.com/recall/37360-redline-daptomycin-500mg-injectable-recall-lack-of-processing-controls · Updated October 5, 2026 · FDA enforcement record: FDA #D-1008-2020
Cite this page
“Redline Daptomycin 500MG Injectable Recall: Lack of Processing Controls.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37360-redline-daptomycin-500mg-injectable-recall-lack-of-processing-controls. Based on FDA recall #D-1008-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1008-2020%22&limit=1).
Why it’s dangerous
The recall is due to a lack of processing controls, which could result in medication errors or improper dosing. This means the product might not be safe for use without proper quality assurance checks.
Who’s affected
Patients receiving Daptomycin 500MG in 0.9% NACL 100ML injectable from Redline Pharmacy Solutions in Hastings, NE are affected. Healthcare providers using this product are at risk of medication errors.
How to tell if you have this one
Check for the product name 'Daptomycin 500MG in 0.9% NACL 100ML Injectable' from Redline Pharmacy Solutions. Affected lots are 02242020@3 and 02242020@9.
- Brand
Redline Pharmacy Solutions- Category
Drug
All 6 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Sold to patients in Nebraska
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1006-2020 | Acetylcysteine Ophthalmic 10% Solution, 5 mL per dropper bottle (10ML). Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901; Lot 02242020@1 | 2x5 ml bottles |
| D-1007-2020 | Morphine Sulfate, 20 mg/mL intrathecal, 20 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901; Lot 02242020@2 | 1 20 ml syringe |
| D-1008-2020 | Daptomycin, 500MG in 0.9% NACL 100ML Injectable Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901; Lots 02242020@3, 02242020@9 | 16 doses |
| D-1009-2020 | Ertapenem in 100ML 0.9% NACL 1GM Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901; Lot 02242020@7 | 8 doses |
| D-1010-2020 | Vancomycin 900MG in 100ML 0.9% NACL Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901; Lot 02242020@8 | 3 doses |
| D-1011-2020 | Morphine Sulfate (MITIGO), 5 mg/mL intrathecal, 40 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901; Lot 02242020@14 | 1 40 ml syringe |
What to do — step by step
Check Product Lot Number
Look for lot numbers 02242020@3 or 02242020@9 on the product label.
Where it went and when
Where it was distributed
Distributed in Nebraska.
FDA distribution: “Sold to patients in Nebraska” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Nebraska.
Recall timeline
FDA terminated this recall 2.1 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1008-2020 (February 24, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1008-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.